Literature DB >> 16963689

Gene therapy for pulmonary diseases.

Martin Kolb1, Gail Martin, Maria Medina, Kjetil Ask, Jack Gauldie.   

Abstract

Gene therapy has not yet met the high expectations of "the early days." However, it is a promising new treatment for lung diseases. Not only single gene disorders such as CF are potential candidates for gene therapy, but also cancer and chronic lung diseases characterized by an imbalance of damaging and protective mechanisms. This review summarizes the recent advances in the development of more efficient gene transfer systems and highlights areas of clinical application of gene therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963689     DOI: 10.1378/chest.130.3.879

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Gene transfer in the lung using recombinant adeno-associated virus.

Authors:  Alisha M Gruntman; Christian Mueller; Terence R Flotte; Guangping Gao
Journal:  Curr Protoc Microbiol       Date:  2012-08

2.  Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats.

Authors:  Ronan J MacLoughlin; Brendan D Higgins; James Devaney; Daniel O'Toole; John G Laffey; Timothy O'Brien
Journal:  Hum Gene Ther       Date:  2015-01       Impact factor: 5.695

Review 3.  Gene therapy for ALI/ARDS.

Authors:  Xin Lin; David A Dean
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

4.  Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.

Authors:  Panagiotis Mastorakos; Adriana L da Silva; Jane Chisholm; Eric Song; Won Kyu Choi; Michael P Boyle; Marcelo M Morales; Justin Hanes; Jung Soo Suk
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

5.  Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library.

Authors:  Mini Thomas; James J Lu; Chengcheng Zhang; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

6.  Gene Therapy for Respiratory Diseases: Progress and a Changing Context.

Authors:  Eric W F W Alton; A Christopher Boyd; Jane C Davies; Deborah R Gill; Uta Griesenbach; Tracy E Harman; Stephen Hyde; Gerry McLachlan
Journal:  Hum Gene Ther       Date:  2020-09       Impact factor: 5.695

7.  Perfluorochemical liquid-adenovirus suspensions enhance gene delivery to the distal lung.

Authors:  Jeffrey A Kazzaz; Marlene S Strayer; Jichuan Wu; Daniel J Malone; Hshi-Chi Koo; Thomas H Shaffer; Jonathan M Davis; David S Strayer; Marla R Wolfson
Journal:  Pulm Med       Date:  2011-08-18

8.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 9.  Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy.

Authors:  Ranmal Avinash Bandara; Ziyan Rachel Chen; Jim Hu
Journal:  Cell Biosci       Date:  2021-07-23       Impact factor: 7.133

10.  Simian virus 40 vectors for pulmonary gene therapy.

Authors:  Luminita Eid; Zohar Bromberg; Mahmoud Abd El-Latif; Evelyn Zeira; Ariella Oppenheim; Yoram G Weiss
Journal:  Respir Res       Date:  2007-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.